ACADIA PHARMACEUTICALS INC (ACAD)
Pharmaceutical Preparations
Latest Price
$25.87
TTM P/E
11.71
Normalized P/E
76.32
Div Yield
--
Book Value
7.32
P/B Ratio
3.53
Valuation metrics
adjust assumptions →EPS: $2.30
Book value / share: $7.21
Formula: √(22.5 × EPS × BVPS)
Graham Number
$19.31
25% downside
Base FCF: $105M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$11.57
55% downside
EPS: $2.30
Target P/E: 76×
Formula: EPS × P/E
P/E Fair Value
$174.80
+576% upside
Institutional Ownership
95.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 42.90M | $954.0M | 25.07% | -- | 2026-03-31 |
| BlackRock, Inc. | 21.55M | $479.0M | 12.60% | +795.5K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.67M | $193.0M | 5.07% | -- | 2026-03-31 |
| STATE STREET CORP | 8.33M | $185.0M | 4.87% | +422.0K | 2026-03-31 |
| RTW INVESTMENTS, LP | 7.14M | $159.0M | 4.18% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.66M | $126.0M | 3.31% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.46M | $77.0M | 2.03% | +225.2K | 2026-03-31 |
| FIRST TRUST ADVISORS LP | 3.34M | $74.0M | 1.95% | +1.07M | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 3.16M | $70.0M | 1.84% | +234.2K | 2026-03-31 |
| Palo Alto Investors LP | 2.87M | $63.0M | 1.68% | +388.7K | 2026-03-31 |